www.benzinga.com Open in urlscan Pro
151.101.194.137  Public Scan

URL: https://www.benzinga.com/pressreleases/22/04/p26479524/demetrix-and-evonik-sign-supply-agreement-for-cannabinoids
Submission: On April 08 via api from DE — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

My account
My Account
Notifications
Log In

QQQ

350.630.98%

DIA

348.140.63%

SPY

449.020.06%

TLT

124.481.59%

GLD

181.250.5%

BTC/USD

43032.460.9659%

FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option
Trades with Nic Chahine"
Visit https://benzingabootcamp.clickfunnels.com/webinar-registrationww2muo3
FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option
Trades with Nic Chahine"
 * 
 * Data & APIs
 * Events
 * Marketfy
 * Premarket

Contribute
Sign in
 * News
   Earnings
   Guidance
   Dividends
   M&A
   Buybacks
   Legal
   Interviews
   Management
   Retail Sales
   Offerings
   IPOs
   Insider Trades
   Biotech/FDA
   Freight
   Politics
   Government
   Healthcare
 * Markets
   Pre-Market
   After Hours
   Movers
   ETFs
   Forex
   Cannabis
   Commodities
   Options
   Binary Options
   Bonds
   Futures
   CME Group
   Global Economics
   Previews
   Reviews
   Small-Cap
   Cryptocurrency
   Penny Stocks
   Digital Securities
 * Ratings
   Analyst Color
   Downgrades
   Upgrades
   Initiations
   Price Target
 * Ideas
   Trade Ideas
   Long Ideas
   Short Ideas
   Technicals
   From The Press
   Jim Cramer
   Rumors
   Best Stocks & ETFs
   Best Penny Stocks
   Best S&P 500 ETFs
   Best Swing Trade Stocks
   Best Blue Chip Stocks
   Best High-Volume Penny Stocks
   Best Small Cap ETFs
 * Fintech
   News
   Podcast
   Events
   Newsletter
 * Personal Finance
   Compare Online Brokers
   Stock Brokers
   Forex Brokers
   Futures Brokers
   Crypto Brokers
   Options Brokers
   ETF Brokers
   Mutual Fund Brokers
   Index Fund Brokers
   Bond Brokers
   Short Selling Brokers
   Stock Apps
   All Broker Reviews
   Insurance
   Auto
   Home
   Medicare
   Life
   Vision
   Dental
   Business
   Pet
   Health
   Motorcycle
   Renters
   Workers Comp
   Top Stocks
   Penny Stocks
   Stocks Under $5
   Stocks Under $10
   Stocks Under $20
   Stocks Under $50
   Stocks Under $100
   Alternative Investing
   Invest in Art
   Invest in Land
   Invest in Real Estate
   Invest in Wine
   Invest in Gold
   Mortgages
   Refinance
   Purchase
   Find a Mortgage Broker
 * Crypto
   Get Started
   Is Bitcoin a Good Investment?
   Is Ethereum a Good Investment?
   What is Blockchain
   Best Altcoins
   How to Buy Cryptocurrency?
   DeFi
   Crypto and DeFi 101
   What is DeFi?
   Decentralized Exchanges
   Best DeFi Yield Farms
   Digital Securities
   NFTs
   NFT Release Calendar
   What is a Non-Fungible Token (NFT)?
   How to Buy Non-Fungible Tokens (NFTs)
   CryptoPunks Watchlist
   Are NFTs a Scam or a Digital Bubble?
   Best In Crypto
   Best Crypto Apps
   Best Crypto Portfolio Trackers
   Best Crypto Day Trading Strategies
   Best Crypto IRA
   Best Cryptocurrency Scanners
   Best Business Crypto Accounts
   Best Crypto Screeners
 * Cannabis
   News
   Earnings
   Interviews
   Deals
   Regulations
   Psychedelics
 * TV
   YouTube
   Video
   Podcasts
 * Trading School


Personal Finance
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Calendars
Analyst Ratings Calendar
Dividend Calendar
Conference Call Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Retail Sales Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Premium

QQQ

350.630.98%

DIA

348.140.63%

SPY

449.020.06%

TLT

124.481.59%

GLD

181.250.5%

BTC/USD

43032.460.9659%

FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option
Trades with Nic Chahine"
Visit https://benzingabootcamp.clickfunnels.com/webinar-registrationww2muo3
FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option
Trades with Nic Chahine"


DEMETRIX AND EVONIK SIGN SUPPLY AGREEMENT FOR CANNABINOIDS

by PRWeb
April 5, 2022 11:30 AM | 3 min read



[TODAY ONLY] Get 50% OFF and get 2 bear market-beating options trades straight
to your inbox and SMS every month! Click Here Now to Get Started!

Demetrix and German global specialty chemicals company Evonik, announce a supply
agreement for cannabinoids to be used in beauty and personal care products. The
first product, CBG (cannabigerol) will be entering the market in 2022.

BERKELEY, Calif. (PRWEB) April 05, 2022

Demetrix and German global specialty chemicals company Evonik, announce a supply
agreement for cannabinoids to be used in beauty and personal care products. The
first product, CBG (cannabigerol) will be entering the market in 2022.

--------------------------------------------------------------------------------

LIVE RIGHT NOW ON YOUTUBE: How to Use Simple Options To Make Money in Volatile
Markets with Wall Street Veteran Matt Maley Click Here NOW to Watch!


--------------------------------------------------------------------------------

Powered By

10



See Which American Lithium Company Saw 707% Growth After They Fight Back Against
China


Share

Next
Stay





Coupling Demetrix's proven production technology and Evonik's leadership
position as a sustainable specialties partner to the top beauty and personal
care brands, this multi-year relationship focuses on bringing cannabinoids to
global markets.

"Evonik is a global leader in supplying innovative solutions to the beauty and
personal care markets in more than 100 countries," says Cynthia Bryant, Demetrix
CBO. "This partnership speaks to the growing demand for high purity cannabinoids
because of the benefits they can provide for consumers."

"Evonik Care Solutions is the sustainability specialties partner. Sustainability
drives our development of products and processes, and we are furthering our
mission by choosing solutions from biotechnology companies like Demetrix. The
industry-leading team at Demetrix and their deep experience in producing
bioactives sustainably complements our formulation and market expertise in
beauty and personal care," says Franck Michoux, Director of Strategy for
Cosmetic Actives Ingredients. "We are eager to work with Demetrix and bring more
of the over 100 cannabinoids to market."



Demetrix provides access to rare bioactive ingredients that its research has
shown to hold promise for health and wellness benefits. The company is initially
focusing on cannabinoids, a class of natural compounds that hold tremendous
potential for the health and beauty industry. Demetrix ingredients do not have
many of the common impurities found with plant extraction that can create
undesirable effects in consumer products.

For more information about Demetrix's bioactive products and sustainability
goals, visit http://www.demetrix.com.

For more information about Evonik's sustainability goals for the beauty and
personal care industry, visit http://www.evonik.com/personal-care.

About Demetrix
Demetrix is a biotechnology company that believes in the power of science to
make the world a better place. The company produces health and wellness products
backed by science, including rare, ultra-high purity cannabinoids for
pharmaceutical and consumer applications. Demetrix's team of industry-leading
experts has enabled the company to bring its first ingredient to market in less
than 5 years from startup – the fastest achieved in the industry. The company is
pioneering the study of the more than 100 rare cannabinoids and their
interactions with the human body. Demetrix is venture-backed and headquartered
in Berkeley, California.

About Evonik
Evonik is one of the world leaders in specialty chemicals. The company is active
in more than 100 countries around the world and generated sales of €15 billion
and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes
far beyond chemistry to create innovative, profitable and sustainable solutions
for customers. About 33,000 employees work together for a common purpose: We
want to improve life today and tomorrow. The focus of the business of the
Nutrition & Care division is on health and quality of life. It develops
differentiated solutions for active pharmaceutical ingredients, medical devices,
nutrition for humans and animals, personal care, cosmetics, and household
cleaning. In these resilient end markets, the division generated sales of €3.56
billion in 2021 with about 5,300 employees.



For the original version on PRWeb visit:
https://www.prweb.com/releases/2022/4/prweb18597787.htm


IF YOU ARE NOT USING THIS TRADING STRATEGY, YOU ARE LEAVING MONEY ON THE
TABLE...

If you are blindly looking up and trading stocks the way 99% of traders are, you
are missing on HUGE potential returns. Even new traders who started following
this options trading strategy instantly began seeing returns they wouldn't have
had otherwise. With even two trades per month with this strategy, you will start
seeing the difference in your trading account. Don't waste any more time
"guessing" and "getting lucky". Click Here to See if you Qualify for Benzinga
Options!



© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights
reserved.

Posted In:


Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on
the internet.
Click to Get Started
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket
Activity Newsletter